Impact of Upper Gastrointestinal Involvement on Clinical Outcomes in Paediatric Inflammatory Bowel Disease
Acta Paediatrica · 04.08.2026
DOI: 10.1111/apa.70720 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Paediatrica, online erschienen am 04.08.2026. Verfasst von Ofek Aloni und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Gastroenterology Institute, Dana-Dwek Children's Hospital, Tel Aviv Sourasky University Medical Center (Ichilov), Tel Aviv, Israel. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aim
The aim of this study was to assess the clinical implications of upper gastrointestinal (UGI) involvement in paediatric inflammatory bowel disease (IBD).
Methods
This retrospective cohort study included children diagnosed with IBD between 2010 and 2023, who underwent a UGI endoscopic evaluation at diagnosis and were followed for at least 12 months. Demographic, clinical, laboratory, endoscopic and histologic data were collected. Outcomes included clinical remission, biomarker remission, need for biologic therapy, IBD‐related hospitalizations and IBD‐related surgeries.
Results
UGI involvement was observed in 210 of 310 (68%) children, with a higher prevalence in CD compared to UC (73% vs. 57%, p = 0.004). Children with UGI involvement had a significantly lower probability to achieve clinical remission (Hazard ratio [HR] = 0.76, 95% confidence interval [CI] 0.59–0.98, p = 0.035) and biomarker remission (HR = 0.60, 95% CI 0.45–0.78, p < 0.001) and were more likely to initiate biologic therapy (HR = 1.77, 95% CI 1.24–2.52, p = 0.001).
Conclusion
UGI involvement is associated with a more severe course of IBD in children and characterized by lower rates of clinical and biomarker remission and a higher likelihood of initiating biologic therapy. These findings highlight the importance of early endoscopic evaluation of the UGI tract in paediatric IBD to guide monitoring and treatment strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Gastroenterology Institute, Dana-Dwek Children's Hospital, Tel Aviv Sourasky University Medical Center (Ichilov), Tel Aviv, Israel.
- Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
ORCID-Profile: Adi Anafy, Hadar Moran-Lev, Achiya Amir, Tut Galai, Shlomi Cohen, Anat Yerushalmy-Feler
Zitieren
APA
Aloni, O., Anafy, A., Moran-Lev, H., Amir, A., Ziv, A., Doyev, R., Galai, T., Cohen, S., & Yerushalmy-Feler, A. (2026). Impact of Upper Gastrointestinal Involvement on Clinical Outcomes in Paediatric Inflammatory Bowel Disease. Acta Paediatrica. https://doi.org/10.1111/apa.70720
Vancouver
Aloni O, Anafy A, Moran-Lev H, Amir A, Ziv A, Doyev R, et al. Impact of Upper Gastrointestinal Involvement on Clinical Outcomes in Paediatric Inflammatory Bowel Disease. Acta Paediatrica. 2026. doi:10.1111/apa.70720
BibTeX
@article{Aloni2026,
author = {Aloni, Ofek and Anafy, Adi and Moran-Lev, Hadar and Amir, Achiya and Ziv, Alma and Doyev, Reut and Galai, Tut and Cohen, Shlomi and Yerushalmy-Feler, Anat},
title = {Impact of Upper Gastrointestinal Involvement on Clinical Outcomes in Paediatric Inflammatory Bowel Disease},
journal = {Acta Paediatrica},
year = {2026},
doi = {10.1111/apa.70720}
}
EUVIMED